Since L-plastin Ser5 phosphorylation promotes the recruitment of L-plastin to invadopodia, ECM degradation and invasion/migration of breast cancer cells, blocking this phosphorylation event might be an interesting alternative to reduce breast cancer cell invasiveness. The gene discussed is LCP1; the disease is breast carcinoma.